GlassScriptPhysician profile
Shannon Boney Mathis
NPI 1013472232
$3,272.14
in general payments reported to CMS, 2019-2025
37 companies · $446 in 2025
The $446 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $199 · 2022: $831 · 2023: $1,674 · 2024: $122 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,199 · Education: $42.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,199.31 |
| Education | $42.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $495.33 | 2022-2023 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $473.08 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $431.11 | 2022-2024 | Farxiga, Breztri |
| Lilly USA, LLC | $219.46 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| E.R. Squibb & Sons, L.L.C. | $199.33 | 2021 | |
| Pfizer INC. | $144.19 | 2023 | |
| Novartis Pharmaceuticals Corporation | $138.98 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.13 | 2022-2025 | Jardiance, Jascayd |
| Biohaven Pharmaceutical Holding Company LTD. | $98.32 | 2022 | |
| Allergan, INC. | $74.12 | 2022 | |
| Insmed, INC. | $61.73 | 2025 | Arikayce |
| Glaxosmithkline, LLC. | $57.23 | 2022-2025 | Trelegy Ellipta, Nucala |
| Verona Pharma, INC. | $51.62 | 2025 | Ohtuvayre |
| Avadel Cns Pharmaceuticals, LLC | $51.24 | 2025 | Lumryz |
| Merck Sharp & Dohme LLC | $49.59 | 2022-2023 | Steglatro, Belsomra |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Mathis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.